NEW YORK (Reuters Health) – Adding midazolam to ketamine for emergency department sedation in adults reduces the occurrence of agitation during recovery, investigators report in the Annals of…
NEW YORK (Reuters Health) – Rosuvastatin halves the rate of primary cardiovascular events in patients who have a high global cardiovascular risk profile, according to a post hoc…
NEW YORK (Reuters Health) – In patients hospitalized for infection, continuing pre-existing statin therapy does not improve outcomes, and discontinuing the therapy does not lead to an inflammatory…
NEW YORK (Reuters Health) – Women who have undergone laparoscopic surgery for endometrioma have a reduced risk of recurrence when they take low-dose oral contraceptives, a Korean team…
NEW YORK (Reuters Health) – High-dose chemo followed by autologous stem-cell transplantation achieves good results in patients with relapsed Hodgkin’s lymphoma, and outcomes are not improved by additional…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
Charles E. Argoff, MD, Professor of Neurology and Director of the Comprehensive Pain Center, Albany Medical Center, describes the side effect profile of topical NSAIDs, which is exactly…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
NEW YORK (Reuters Health) – For patients with advanced HIV disease –either AIDS or a CD4 count below 200 — initial antiretroviral regimens based on efavirenz or ritonavir-boosted…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…